XENOSOURCE
Dead / Abandoned — Abandoned — no statement of use filed (as of 19 May 2025)
What this means for you
This application is over — abandoned 19 May 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98096475
- Mark type
- Stylized text
- Filed
- 21 Jul 2023
- Published for opposition
- 20 Aug 2024
- Abandoned
- 19 May 2025
- Attorney of record
- Brad Y. Chin
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical drug development services; medical and scientific research services in the field of cancer diagnosis, therapy, prevention, and treatment; development of translational research tools for the collection, analysis, grooming, sale, and license of preclinical and clinical data and patient derived xenograft models related to the treatment of oncology; medical and scientific research, namely, translational research for the collection, analysis, grooming, sale, and license of preclinical and clinical data and patient derived xenograft models for the treatment of oncology
Owner
- South Texas Accelerated Research Therapeutics, LLC, San Antonio, TX, US
- South Texas Accelerated Research Therapeutics, LLC, San Antonio, TX, US
Prior registrations
Prosecution history
- 19 May 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 19 May 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Aug 2024 — PUBLISHED FOR OPPOSITION
- 31 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Jul 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Apr 2024 — ASSIGNED TO EXAMINER
- 04 Apr 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 04 Apr 2024 — NON-FINAL ACTION E-MAILED
- 04 Apr 2024 — NON-FINAL ACTION WRITTEN
- 25 Mar 2024 — ASSIGNED TO EXAMINER